PBPK modeling of ivermectin-Considerations for the purpose of developing alternative routes to optimize its safety profile by Karen Rowland Yeo, David Wesche

Connect to this object online.

Addressing drug safety of maternal therapy during breastfeeding using physiologically‐based pharmacokinetic modeling by Xian Pan, Karen Rowland Yeo

Connect to this object online.

Physiologically‐Based Pharmacokinetic Modeling for Predicting Drug Interactions of a Combination of Olanzapine and Samidorphan by Lei Sun, Lisa vonMoltke, Karen Rowland Yeo

Connect to this object online.

Medicines in pregnancy: A clinical pharmacology extrapolation framework to address knowledge gaps by Paola Coppola, Eva Gil Berglund, Karen Rowland Yeo

Connect to this object online.

Increasing application of pediatric physiologically based pharmacokinetic models across academic and industry organizations by Trevor N. Johnson, Ben G. Small, Karen Rowland Yeo

Connect to this object online.

Recent applications of pharmacometrics and systems pharmacology approaches to improve and optimize drug therapy for pregnant and lactating women by Priya Jayachandran, Jane Knöchel, Brian Cicali, Karen Rowland Yeo

Connect to this object online.

A tutorial on physiologically based pharmacokinetic approaches in lactation research by Amita Pansari, Xian Pan, Lisa M. Almond, Karen Rowland‐Yeo

Connect to this object online.

Using physiologically‐based pharmacokinetic modeling for predicting the effects of hepatic impairment on the pharmacokinetics of olanzapine and samidorphan given as a combination t... by Lei Sun, Zoe Barter, Lisa vonMoltke, Karen Rowland Yeo

Connect to this object online.

Physiologically Based Pharmacokinetic Modelling to Predict Imatinib Exposures in Cancer Patients with Renal Dysfunction: A Case Study by Karen Rowland Yeo, Oliver Hatley, Ben G. Small, Trevor N. Johnson

Connect to this object online.

Supplementing clinical lactation studies with PBPK modeling to inform drug therapy in lactating mothers: Prediction of primaquine exposure as a case example by Xian Pan, Khaled Abduljalil, Lisa M. Almond, Amita Pansari, Karen Rowland Yeo

Connect to this object online.

A best practice framework for applying physiologically‐based pharmacokinetic modeling to pediatric drug development by Trevor N. Johnson, Ben G. Small, Eva Gil Berglund, Karen Rowland Yeo

Connect to this object online.

Using PBPK modeling to supplement clinical data and support the safe and effective use of dolutegravir in pregnant and lactating women by Jia Ning, Amita Pansari, Karen Rowland Yeo, Aki T. Heikkinen, Catriona Waitt, Lisa M. Almond

Connect to this object online.

Evaluation of the drug-drug interaction potential of brigatinib using a physiologically‐based pharmacokinetic modeling approach by Michael J. Hanley, Karen Rowland Yeo, Meera Tugnait, Shinji Iwasaki, Narayana Narasimhan, Pingkuan Zhang, Karthik Venkatakrishnan, Neeraj Gupta

Connect to this object online.

The use of quantitative clinical pharmacology approaches to support moxidectin dosing recommendations in lactation. by Nolan D Wood, Danelle Smith, Sally A Kinrade, Mark T Sullivan, Craig R Rayner, David Wesche, Kashyap Patel, Karen Rowland-Yeo

Connect to this object online.

Prediction of CYP‐mediated DDIs involving inhibition: Approaches to address the requirements for system qualification of the Simcyp Simulator by Peter J. Kilford, Kuan‐Fu Chen, Kim Crewe, Iain Gardner, Oliver Hatley, Alice Ban Ke, Sibylle Neuhoff, Mian Zhang, Karen Rowland Yeo

Connect to this object online.

CPT: Pharmacometrics & Systems Pharmacology - Inception, Maturation, and Future Vision by Karen Rowland Yeo, Stefanie Hennig, Sriram Krishnaswami, Natasha Strydom, Vivaswath S. Ayyar, Jonathan French, Vikram Sinha, Eric Sobie, Ping Zhao, Lena E. Friberg, France Mentré

Connect to this object online.

Advancing the utilization of real‐world data and real‐world evidence in clinical pharmacology and translational research-Proceedings from the ASCPT 2023 preconference workshop by Jing Liu, Karen Rowland‐Yeo, Almut Winterstein, Simon Dagenais, Qi Liu, Jeffrey S. Barrett, Rui Zhu, Cyrus Ghobadi, Amita Datta‐Mannan, Joy Hsu, Sujatha Menon, Mariam Ahmed, Pooja Manchandani, Paulien Ravenstijn

Connect to this object online.

Development and application of a PBPK modeling strategy to support antimalarial drug development by Nada Abla, Eleanor Howgate, Karen Rowland‐Yeo, Maurice Dickins, Mackenzie C. Bergagnini‐Kolev, Kuan‐Fu Chen, Savannah McFeely, Jennifer J. Bonner, Laura G. A. Santos, Nathalie Gobeau, Howard Burt, Zoe Barter, Hannah M. Jones, David Wesche, Susan A. Charman, Jörg J. Möhrle, Jeremy N. Burrows, Lisa M. Almond

Connect to this object online.